AI could shift clinical supply from periodic forecasting to continuous decisions, linking live signals with execution while protecting quality and patient continuity now.
- How To Build Clinical Supply Into Drug Development From The Start
- When Communication Fails, Clinical Supply Risk Grows
- When IRT Configuration Decisions Disrupt Clinical Supply
- Fixing The Data Problem Before AI Can Help Clinical Trial Supply
- The Shipment Arrived. The Inventory Didn't: Understanding The Hidden Data Dependencies Behind Depot-To-Site Deliveries
- Building Stronger Sponsor–Vendor Relationships
- When Clinical Supply Plans Meet Site Reality: Lessons From The Front Line
- Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
ON-DEMAND WEBINARS
This webinar discusses the types of master protocols and how configurable, modern RTSM systems enable fast and seamless mid-study changes to help you efficiently run your master protocol study.
Explore the opportunities to optimize your supply chain strategy and facilitate direct-to-site, direct-to-patient and hybrid services utilizing a global GMP depot network.
Learn how RTSM can be tailored to meet precision medicine’s unique challenges of expiry, visit & personalized shipment management.
Learn how demand-led and hybrid clinical supply models reduce waste, accelerate timelines, and improve flexibility for global trials through regional hubs and patient-specific packaging strategies.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![GettyImages-1404326328 computer, research]( "From Frustration To Organization: An SSO Platform For Trial Sites")
From Frustration To Organization: An SSO Platform For Trial SitesTo reap the benefits of tech innovation, sponsors and sites need a single sign-on (SSO) solution that enables streamlined organization across different trials and clinical systems.
-
![GettyImages-184945838-cold-chain-cryopreservation]( "Prepping For Commercialization Through Supply Chain Logistics")
Prepping For Commercialization Through Supply Chain LogisticsWhile cell and gene therapies are bringing new hope to patients experiencing rare and serious diseases, uncover how they're disrupting the biopharma market in new and challenging ways.
-
![GettyImages-2170642314-year 2025]( "What Does 2025 Hold For Pharma?")
What Does 2025 Hold For Pharma?Look at what’s in store for pharma and life science in 2025. While we see many recurring themes, 2025 promises to be filled with unexpected — and possibly unprecedented — developments.
-
![GettyImages-2167387195-computer-graphs-hand-team-digital]( "Outgrowing Excel: Implementing RTSM In A Live Phase I Trial")
Outgrowing Excel: Implementing RTSM In A Live Phase I TrialLearn how a clinical-stage oncology biotech successfully transitioned a live Phase I trial from manual spreadsheets to RTSM without disrupting site momentum or patient enrollment.
-
![GettyImages-1368429013-vial]( "Overcoming Challenges In Cell And Gene Therapy Containment")
Overcoming Challenges In Cell And Gene Therapy ContainmentReview the hurdles that can slow your time to market, including the challenges in packaging high-value therapies and solutions to help you mitigate risk and simplify the journey.
-
![iStock-1214764688-scientist-lab-analyze-research]( "Global Clinical Supply Solutions For Every Trial")
Global Clinical Supply Solutions For Every TrialA reliable clinical supply chain strategy is as essential as a company’s discovery program. Seek a partner who can help guide a comprehensive strategy and manage day-to-day activities.
-
![patient clinical iStock-1174583087.jpg]( "How Clinical Trial Complexity Impacts End Users")
How Clinical Trial Complexity Impacts End UsersThis article examines clinical trial complexity through the lens of study investigators, site staff, CRAs, sponsor study and supply managers, and how the RTSM/ IRT provides the ability to be as creative as needed.
-
![GettyImages-1181190018 supply chain pharma, bio]( "End-To-End Inventory Control Supports Biotech's Expanding Portfolio")
End-To-End Inventory Control Supports Biotech's Expanding PortfolioMany organizations struggle with siloed operations, but this modern GxP inventory solution solves these challenges by providing a centralized, cloud-based platform for end-to-end visibility.
-
![Getty-1652511983-supply-chain-management]( "Hidden Benefits Of Clinical Forecasting & Supply Planning Solutions")
Hidden Benefits Of Clinical Forecasting & Supply Planning SolutionsStreamline clinical supply chain management with SmartSignals Supplies, reducing errors and inefficiencies from spreadsheet-based forecasting.
-
![GettyImages-184945838-cold-chain-cryopreservation]( "Building A Global Cell And Gene Supply Chain Serving Personalized Medicine")
Building A Global Cell And Gene Supply Chain Serving Personalized MedicineClinical distribution paths can be fragile for a multitude of reasons, making it critical that pharmaceutical sponsors and their partners orchestrate supply chain logistics even before site initiation.
- Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next
- The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon.
- How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies
- First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.
